- QOMEL

Nomu - Parallel Market (Kingdom of Saudi Arabia)
52.1 Last Update 25/06/2025 15:01 KSA
× Warning! {{companyMessage}}
  • :52.1
  • :52.1
  • ('000):35,000
  • ( '000):1,823,500
  • :0


  • 0
  • :0
  • :
  • 52-W L52-W H
    52.1
    47139
  • 62.52%
  • 10.85%


  • 0

  • ():

    0
  • ():505,260
  • :0
  • Performance Comparison

Activities

Qomel Co. is a prominent healthcare company based in Riyadh, Saudi Arabia. Established in 2007, Qomel has rapidly grown to become one of the leading players in the healthcare sector in the region. The company operates across various healthcare domains, including pharmaceuticals, medical services, and healthcare solutions.

Key Areas of Operation
Pharmaceuticals: Qomel is strategically positioned within the pharmaceutical industry, leveraging its wide customer base, experienced team, and strategic partnerships with international pharmaceutical manufacturers. The company ensures a diversified portfolio of well-supplied medications that cater to the health needs of the Saudi market.
Medical Services: Qomel provides a range of medical services, including ophthalmology, dental care, and wound care. The company is known for its high-quality medical care facilities and comprehensive healthcare services.
Healthcare Solutions: Qomel offers a full spectrum of healthcare solutions, including distribution, sales and marketing, pharmacovigilance (PV), and regulatory affairs. The company operates with high efficiency in manufacturing and distribution, reducing costs and improving service delivery.

Vision and Mission
Vision: To improve the quality of healthcare and provide individuals with access to high-quality, comprehensive medical services. Qomel aims to be the preferred choice for patients and families seeking reliable medical care.
Mission: To provide innovative medical services and comprehensive healthcare to patients, ensuring quality and comfort. Qomel is committed to achieving patient satisfaction through medical excellence and professional treatment.

Strengths and Competitive Advantages
Experienced Leadership: Qomel boasts a team with extensive experience and in-depth knowledge across various operational fields, including distribution, sales, marketing, PV, and regulatory affairs. This expertise enables the company to navigate complex market dynamics effectively.
Operational Efficiency: Utilizing advanced systems, Qomel operates with high efficiency in manufacturing and distribution, enhancing profitability and allowing for reinvestment in research and development.
Flexibility and Adaptability: Qomel demonstrates remarkable flexibility and adaptability in an ever-changing market environment, ensuring the company can respond swiftly to shifts in consumer demand and regulatory changes.

Recent Developments
Qomel has been actively involved in expanding its operations and enhancing its market presence. The company continues to invest in research and development, strategic partnerships, and innovative healthcare solutions to meet the evolving needs of the healthcare sector.

  • Chairman:
    Dr. Nasser A. Al-Mubarak
  • Vice-chairman:
    Bandar A. Al-Namer
  • CEO:
    Hisham A. Al-Agla
  • Board Members:

    Dr. Sultan A. Al-Mubarak

    Hamad A. Al-Manea

    Hisham A. Al-Agla

  • Auditors:

    RSM - Allied Accountants

Chief Financial Officer (CFO)

Sherif M. El-Sayegh
Announced On Period As Of Net Profit (SAR Mil) Growth (%)
24/02/2025 12-Month 31/12/2024 22 24.79
Market Cap
US$ Mil
Last Price
Local Cry
Price Change (%)
1 Day
Price Change (%)
1 Year
P/E TTM P/B MRQ Dividend Yield (%) Beta ROA (%) ROE (%)
SULAIMANALHABIB 24,717.88 261.2 -1.44 -10.1 41.66 0 0 0 0 0
PUREHEALTH 7,621.6 2.6 3.17 -25.71 24.93 0 0 0 0 0
ARMAH 7,504.71 86 0.35 0 0 0 0 0 0 0
NAHDI 4,379.13 128 1.26 -11.38 19.72 0 0 0 0 0
MOUWASAT 3,890.9 73.3 0.41 -36.4 22.19 2.63 0 0.81 13.85 22.49
JAMJOOMPHARMA 3,178.81 170.2 -0.12 24.34 34.14 0 0 0 0 0
DALLAHHEALTH 3,144.66 122 0.99 -28.61 23.25 4.39 0 0.93 12.1 17.53
FAKEEHCARE 2,562.77 40.95 -1.21 0 35.71 0 0 0 0 0
AME 2,130.4 117.8 3.15 0 0 0 0 0 0 0
CARE 1,878.94 161.2 2.54 -19.96 25.69 7.31 0 0.85 -0.59 -0.89
NABAALSAHA 1,874.83 67 0 0 0 0 0 0 0 0
ALMOOSA 1,867.87 158 -0.13 0 115.7 0 0 0 0 0
TIBBIYAH 1,769.56 33.2 0 0 0 0 0 0 0 0
SAUDIGERMANHEALTH 1,358.89 56 1.08 -27.4 24.12 3.12 0 0.79 11.92 18.76
PROMEDEX 802.17 88 2.32 0 0 0 0 0 0 0
SPIMACO 789.91 25.55 3.44 -16.2 46.11 1.12 0 0.91 8.47 15.11
ALMUJTAMAMEDICAL 768.39 30.2 -0.5 0 0 0 0 0 0 0
AVALONPHARMA 642.8 120.2 -0.34 -5.74 29.98 0 0 0 0 0
MIRAL 545.79 102.2 -0.2 0 0 0 0 0 0 0
QOMEL 485.96 52.1 0 0 0 0 0 0 0 0
MIDAN 485.01 730 0 -5.39 12.96 1.27 0 0 12.06 17.87
JULPHAR 411.93 1.3 -0.77 45.16 33.94 0.64 5.27 0.2 4.09 0
MCGS 391.61 5.1 -0.2 15.38 23.23 0.14 5.86 0.98 6.76 7.99
ATC.KW 387.32 711 -9.66 126.88 167.69 2.39 1.82 -0.01 2.93 12.88
GMPC 380.49 1.97 -1.5 17.88 0 1.06 3 -0.08 75.81 111.42
LANA 371.29 38.7 0 0 0 0 0 0 0 0
AYYAN 340.07 12.72 0.31 -31.78 4.93 1.27 0 0.81 -2 -2.64
EQUIPMENTHOUSE 292.22 36.85 0.82 -24.75 22.8 0 0 0 0 0
RPM 240.08 4.4 -0.23 23.56 0 0 0 0 0 0
TMC 202.33 18.98 0 0 0 0 0 0 0 0
BURJEEL 184.19 1.33 2.3 -48.36 1.45 0 0 0 0 0
CMCER 139.33 6.82 0.44 0 0 0 0 0 0 0
ALMODAWAT 117.09 20 8.1 0 0 0 0 0 0 0
QGMD 46.23 1.46 -0.69 -15.42 -2.41 0.25 0 0.76 -6.18 0
FUTURECARE 37.04 2.6 -6.48 0 0 0 0 0 0 0
SMILECARE 26.38 5 1.01 0 0 0 0 0 0 0
BALSMMEDICAL 26.18 78.6 0 0 0 0 0 0 0 0
ALRAZI 16.41 39.5 -2.47 0 0 0 0 0 0 0
FUTUREVISION 15.22 5.71 0 0 0 0 0 0 0 0
JANA 11.56 13.22 -2.08 0 0 0 0 0 0 0